Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Although a subset of patients with chronic obstructive pulmonary disease (COPD) display anemia, the role of elevated pro-inflammatory cytokines in COPD-related anemia of chronic disease (ACD) has not been fully investigated. AIM: To examine the levels of interleukin (IL)-1β, IL-6, IL-10, tumor necrosis factor-alpha (TNFα), interferon-gamma (IFNγ), C-reactive protein (CRP) and erythropoietin in stable COPD outpatients with and without ACD. DESIGN: A case-control design was followed. METHODS: Fifty-four patients with stable COPD were studied. Among them, 27 had ACD according to strict clinical and laboratory criteria (group of cases), while another 27 nonanemic COPD patients, carefully matched to cases for age, gender, height, lung function and smoking status represented the controls. Serum levels of IL-1β, IL-6, IL-10, TNFα, IFNγ, CRP and erythropoietin were measured in both groups. RESULTS: Patients with ACD had significantly higher levels of IL-10 [25.6 (1.9-95.2) vs. 4.1 (1.9-31.9) pg/ml, P = 0.049] and IFNγ [15.2 (2.2-106.9) vs. 2 (1.2-18.3) pg/ml, P = 0.026] and had more frequently elevated CRP than controls. Levels of IL-1β [26.2 (9.8-96.4) vs. 7.9 (2.1-28.4) pg/ml, P = 0.073], IL-6 [20.3 (2.1-125.4) vs. 6.2 (1.2-33.8) pg/ml, P = 0.688] and TNFα [30.1 (3.2-107.5) vs. 10.1 (3.2-50.4) pg/ml, P = 0.131] were also higher in cases, but the differences did not reach statistical significance. Patients with ACD also displayed significantly higher erythropoietin levels than controls [(21.9 (8.4-101.7) vs. 9.7 (6.3-21.7) mIU/ml, P = 0.010], indicating erythropoietin resistance. CONCLUSION: This study shows that in stable COPD outpatients with strictly defined ACD, levels of inflammatory mediators and erythropoietin are elevated compared to nonanemic controls.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, AI shares features with the renal anemia observed in patients with chronic kidney disease (CKD), the anemia in patients with chronic obstructive pulmonary disease (COPD), the anemia in patients with CHF without or with cardio-renal syndrome, and the anemia of the elderly [23, 27, 28].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [28]
Citations
Cites
Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034805 · Cited by 15,627
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Celli, B. R., MacNee, W., Agusti, A., Anzueto, A., Berg, B., Buist, A. S., Calverley, P. M. A., Chavannes, N., Dillard, T., Fahy, B., et al. (2004) · European Respiratory Journal · doi:10.1183/09031936.04.00014304 · Cited by 4,421
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650
Systemic manifestations and comorbidities of COPD
Barnes, P. J., & Celli, B. R. (2009) · European Respiratory Journal · doi:10.1183/09031936.00128008 · Cited by 1,820
Fedorak, R. N., Gangl, A., Elson, C. O., Rutgeerts, P., Schreiber, S., Wild, G., Hanauer, S. B., Kilian, A., Cohard, M., LeBeaut, A., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20229 · Cited by 512
Cytometric bead array: a multiplexed assay platform with applications in various areas of biology
Morgan, E., Varro, R., Sepulveda, H., Ember, J. A., Apgar, J., Wilson, J., Lowe, L., Chen, R., Shivraj, L., Agadir, A., et al. (2004) · Clinical Immunology · doi:10.1016/j.clim.2003.11.017 · Cited by 506
Cytokine-mediated regulation of iron transport in human monocytic cells
Ludwiczek, S., Aigner, E., Theurl, I., & Weiss, G. (2003) · Blood · doi:10.1182/blood-2002-08-2459 · Cited by 420
Update on Cobalamin, Folate, and Homocysteine
Carmel, R., Green, R., Rosenblatt, D. S., & Watkins, D. (2003) · Hematology · doi:10.1182/asheducation-2003.1.62 · Cited by 391
Erythropoietin resistance: the role of inflammation and pro‐inflammatory cytokines
Macdougall, I. C., & Cooper, A. C. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_11.39 · Cited by 336
Haemoglobin level and its clinical impact in a cohort of patients with COPD
Cote, C., Zilberberg, M. D., Mody, S. H., Dordelly, L. J., & Celli, B. (2007) · European Respiratory Journal · doi:10.1183/09031936.00137106 · Cited by 258
Neurohumoral activation as a link to systemic manifestations of chronic lung disease
Andreas, S., Anker, S. D., Scanlon, P. D., & Somers, V. K. (2005) · Chest · doi:10.1378/chest.128.5.3618 · Cited by 243
Prognostic Value of the Hematocrit in Patients With Severe COPD Receiving Long-term Oxygen Therapy
Chambellan, A., Chailleux, E., & Similowski, T. (2005) · Chest · doi:10.1378/chest.128.3.1201 · Cited by 241
Tettamanti, M., Lucca, U., Gandini, F., Recchia, A., Mosconi, P., Apolone, G., Nobili, A., Tallone, M. V., Detoma, P., Giacomin, A., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.023101 · Cited by 239
Lee, P., Peng, H., Gelbart, T., & Beutler, E. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403108101 · Cited by 221
Anemia and Inflammation in COPD
John, M., Hoernig, S., Doehner, W., Okonko, D. D., Witt, C., & Anker, S. D. (2005) · Chest · doi:10.1378/chest.127.3.825 · Cited by 202
Role of IL-10 for induction of anemia during inflammation
Tilg, H., Ulmer, H., Kaser, A., & Weiss, G. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.2204 · Cited by 181
Regulation of Hepcidin and Iron-Overload Disease
Lee, P. L., & Beutler, E. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092205 · Cited by 174
Tzanakis, Ν., Anagnostopoulou, U., Filaditaki, V., Christaki, P. I., & Siafakas, N. M. (2004) · CHEST Journal · doi:10.1378/chest.125.3.892 · Cited by 151
Lieb, R. (2013) · Springer eBooks · doi:10.1007/978-1-4419-1005-9_45 · Cited by 148
Molecular pathogenesis of anemia of chronic disease
Ganz, T. (2006) · Pediatric Blood & Cancer · doi:10.1002/pbc.20656 · Cited by 118
Wang, C. Q., Udupa, K. B., & Lipschitz, D. A. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041620116 · Cited by 107
Elevated IL-10 plasma levels correlate with poor prognosis in diffuse large B-cell lymphoma.
Lech‐Marańda, E., Bienvenu, J., Michallet, A., Houot, R., Robak, T., Coiffier, B., & Salles, G. A. (2006) · PubMed · Cited by 90
Boutou, A., Stanopoulos, I., Pitsiou, G., Kontakiotis, T., Kyriazis, G., Sichletidis, L. T., & Argyropoulou, P. (2011) · Respiration · doi:10.1159/000326899 · Cited by 84
Self-citationCurrent Status of the Measurement of Blood Hepcidin Levels in Chronic Kidney Disease
Macdougall, I. C., Malyszko, J., Hider, R. C., & Bansal, S. S. (2010) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.05990809 · Cited by 82
Anemia, costs and mortality in Chronic Obstructive Pulmonary Disease
Halpern, M. T., Zilberberg, M. D., Schmier, J. K., Lau, E., & Shorr, A. F. (2006) · Cost Effectiveness and Resource Allocation · doi:10.1186/1478-7547-4-17 · Cited by 73
Minas, M., Chrisi, H., Karetsi, E., Papaioannou, A. Ι., Tsarouchaa, K. T. R., Gogou, E., Gourgoulianis, K. I., & Κostikas, Κ. (2010) · Primary Care Respiratory Journal · doi:10.4104/pcrj.2010.00034 · Cited by 73
Krishnan, G., Grant, B. J. B., Muti, P. C., Mishra, A., Ochs‐Balcom, H. M., Freudenheim, J. L., Trevisan, M., & Schünemann, H. J. (2006) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-6-23 · Cited by 71
Markoulaki, D., Κostikas, Κ., Papatheodorou, G., Koutsokera, A., Alchanatis, M., Bakakos, P., Gourgoulianis, K. I., Roussos, C., Koulouris, N. G., & Loukides, S. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.07.010 · Cited by 67
Assessment of bone marrow and body iron stores: old techniques and new technologies.
Gm, B., Eh, D., & Jw, H. (1981) · PubMed · Cited by 59
Hodge, G. L., Hodge, S. J., Haslam, R., McPhee, A. J., Sepulveda, H., MORGAN, E., Nicholson, I., & Zola, H. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02529.x · Cited by 52
Advancements in anemias related to chronic conditions
Guidi, G. C., & Santonastaso, C. L. (2010) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2010.264 · Cited by 45
Inhibition of erythropoietin production in vitro by human interferon gamma
Vannucchi, A. M., Grossi, A., Rafanelli, D., Statello, M., Cinotti, S., & Rossi-Ferrini, P. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04864.x · Cited by 40
van Helvoort, H. A. C., Heijdra, Y. F., & Dekhuijzen, P. N. R. (2006) · Respiration · doi:10.1159/000091117 · Cited by 23
Effect of Interleukin 10 on the Hematopoietic Progenitor Cells from Patients with Aplastic Anemia
Asano, Y., Shibata, S., Kobayashi, S., Okamura, S., & Niho, Y. (1999) · Stem Cells · doi:10.1002/stem.170147 · Cited by 17
Research works printed but not linked: 3
- Brittenham, 1981, Seminars in hematology, 18, 194
- Lech-Maranda, 2006, European cytokine network, 17, 60
- 2000, 119, 1473
Cited by
Marques, O., Weiss, G., & Muckenthaler, M. U. (2022) · Blood · doi:10.1182/blood.2021013472 · Cited by 160
Erythropoiesis: insights into pathophysiology and treatments in 2017
Zivot, A., Lipton, J. M., Narla, A., & Blanc, L. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0011-z · Cited by 163
Nairz, M., Theurl, I., Wolf, D., & Weiss, G. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0505-7 · Cited by 152
Iron Deficiency Anemia—Bridging the Knowledge and Practice Gap
Shander, A., Goodnough, L. T., Javidroozi, M., Auerbach, M., Carson, J. L., Ershler, W. B., Ghiglione, M., Glaspy, J. A., & Lew, I. (2014) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2014.05.001 · Cited by 130
“Some evidence suggests anemic COPD patients may have high levels of erythropoietin indicative of some degrees of erythropoietin resistance [88], while others have observed reduced level of erythropoietin during COPD exacerbation [89,90].”
BackgroundThe “Iron”-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease
Cloonan, S. M., Mumby, S., Adcock, I. M., Choi, A. M. K., Chung, K. F., & Quinlan, G. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201702-0311pp · Cited by 106
Metadata
- Authors
- Boutou, A. K., Pitsiou, G. G., Stanopoulos, I., Kontakiotis, T., Kyriazis, G., & Argyropoulou, P.
- Affiliations
- Aristotle University of Thessaloniki (GR)
- Venue
- QJM
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-02-21
- Volume
- 105
- Issue
- 7
- Pages
- 657-663
- ISSN
- 0033-5622 (ISSN-L)
- 1460-2725
- 1460-2393
- OpenAlex
- W2156953095
- Cited by
- 37
- References
- 36
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 3 · 2022: 1 · 2020: 3 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 4 · 2015: 5 · 2014: 4 · 2013: 4 · 2012: 3
- FWCI
- 4.12
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- QJM (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- chronic obstructive pulmonary disease, anemia of chronic disease, inflammatory mediators, inflammatory cytokines, IL-10, interferon-gamma, C-reactive protein, erythropoietin, interleukin-6, TNF-α, IL-1β, serum cytokine levels, COPD severity
- MeSH terms
- Aged, Anemia, C-Reactive Protein, Erythropoietin, Female, Humans, Male, Middle Aged, Biomarkers, Case-Control Studies, Cytokines, Inflammation Mediators, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.